---
schema_version: "secwatch.filing_event.v1"
accession: "0001384101-26-000008"
form_type: "8-K"
ticker: "VCYT"
cik: "0001384101"
company_name: "VERACYTE, INC."
filed_at: "2026-02-25T23:59:59+00:00"
generated_at: "2026-05-16T00:11:03.794488+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Veracyte Q4 revenue $140.6M (+19% YoY); GAAP net income $41.1M, generates $52.6M operating cash

## Summary
- Q4 total revenue $140.6M (+19% YoY); testing revenue $135.8M (+21%); total volume 48,019 tests (+16%).
- Decipher revenue $85.6M (+27%); Afirma revenue $47.9M (+16%); strong double-digit growth in both segments.
- GAAP net income $41.1M (29.3% margin); adjusted EBITDA $42.3M (30.1% margin); $52.6M operating cash flow.
- Full-year 2025 revenue $517.1M (+16% YoY); GAAP net income $66.4M; adjusted EBITDA $142.5M; operating cash $136.3M.
- Ended 2025 with $412.9M cash; plans to launch Prosigna LDT and TrueMRD test in 2026.

## SEC filing metadata
- accession: 0001384101-26-000008
- form_type: 8-K
- ticker: VCYT
- cik: 0001384101
- company_name: VERACYTE, INC.
- filed_at: 2026-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1384101/000138410126000008/0001384101-26-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1384101/000138410126000008/vcyt-20260225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001384101-26-000008
- JSON: https://secwatch.observer/filing/0001384101-26-000008.json
- Plain text: https://secwatch.observer/filing/0001384101-26-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.